Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov;9(22):e2001117.
doi: 10.1002/adhm.202001117. Epub 2020 Oct 11.

Biomineralization: An Opportunity and Challenge of Nanoparticle Drug Delivery Systems for Cancer Therapy

Affiliations
Review

Biomineralization: An Opportunity and Challenge of Nanoparticle Drug Delivery Systems for Cancer Therapy

Weicai Wang et al. Adv Healthc Mater. 2020 Nov.

Abstract

Biomineralization is a common process in organisms to produce hard biomaterials by combining inorganic ions with biomacromolecules. Multifunctional nanoplatforms are developed based on the mechanism of biomineralization in many biomedical applications. In the past few years, biomineralization-based nanoparticle drug delivery systems for the cancer treatment have gained a lot of research attention due to the advantages including simple preparation, good biocompatibility, degradability, easy modification, versatility, and targeting. In this review, the research trends of biomineralization-based nanoparticle drug delivery systems and their applications in cancer therapy are summarized. This work aims to promote future researches on cancer therapy based on biomineralization. Rational design of nanoparticle drug delivery systems can overcome the bottleneck in the clinical transformation of nanomaterials. At the same time, biomineralization has also provided new research ideas for cancer treatment, i.e., targeted therapy, which has significantly better performance.

Keywords: biomineralization; cancer therapy; drug delivery; inorganic materials; organic templates.

PubMed Disclaimer

Similar articles

Cited by

References

    1. R. L. Siegel, K. D. Miller, A. Jemal, Ca-Cancer J. Clin. 2019, 69, 7.
    1. a) X. Zhao, S. Liu, C. Hu, Y. Liu, M. Pang, J. Lin, ACS Appl. Bio Mater. 2019;.
    1. b) J. Shen, Q. Wang, Y. Lv, J. Dong, G. Xuan, J. Yang, D. Wu, J. Zhou, G. Yu, G. Tang, ACS Biomater. Sci. Eng. 2019, 5, 4463;
    1. c) T. A. Ahles, A. J. Saykin, Nat. Rev. Cancer 2007, 7, 192.
    1. a) A. El-Kenawi, K. Hänggi, B. Ruffell, Cold Spring Harbor Perspect. Med. 2019, 10, a037424;

Publication types

LinkOut - more resources